中西医药治疗自身免疫性肝病研究进展

doi:10.3969/j.issn.1672-5069.2020.03.038

Abstract

Abstract: Objective The morbidity of autoimmune liver disease (AILD) is increasing year by year, and it is one of the hotspots in research on liver diseases. Western medicine has definite curative efficacy, while it combines with traditional Chinese herbal medicine might benefit patients more by improving the efficacy, reducing side effects, improving patient's quality of life, and prolonging survival time. This article reviews the current progress on herbal and western medicine combination in treatment of patients with AILD.

Key words: Autoimmune hepatitis, Primary biliary cholangitis, Primary sclerosing cholangitis, Herbal medicine, Therapy

Zhu Bukun, Li Gang, Zhang Wei.. Chinese herbal and western medicine combination in treatment of patients with autoimmune liver disease[J]. Journal of Practical Hepatology, 2020, 23(3): 453-456.

References

[1] Górski AE JończykMatysiak M, Szelachowska L, et al. Therapeutic potential of phages in autoimmune liver diseases. Clin Exp Immunol, 2018,192(1):1-6.
[2] Webb GJ, Hirschfield GM, Krawitt EL, et al. Cellular and molecular mechanisms of autoimmune hepatitis. Annu Rev Pathol,2018,13: 247-292.
[3] Wang Q, Yang F, Miao Q, et al.The clinical phenotypes of autoimmune hepatitis: A comprehensive review. J Autoimmun,2016,66: 98-107.
[4] Hennes E M, Zeniya M, Czaja A J, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology, 2008, 48(1):169-176.
[5] Roberts SK, Kemp W.Salvage therapies for autoimmune hepatitis: A critical review.Sem Liver Dis,2017,37(4):343-362.
[6] 中华医学会肝病学分会.自身免疫性肝炎诊断和治疗共识(2015). 胃肠病学, 2016, 21(3):165-178.
[7] Czaja AJ. The prevention and reversal of hepatic fibrosis in autoimmune hepatitis. Aliment Pharmacol Ther,2014,39(4):385-406.
[8] European Association for the Study of the Liver. EASL Clinical Practice Guidelines:Autoimmune hepatitis.J Hepatol, 2015,63(4):971-1004.
[9] Purnak T, Efe C, Kav T, et al. Treatment response and outcome with two different prednisolone regimens in autoimmune hepatitis. Dig Dis Sci, 2017, 62(10):2900-2907.
[10] Tan P, Marotta P, Ghent C, et al. Early treatment response predicts the need for liver transplantation in autoimmune hepatitis. Liver Int, 2005,25(4):728-733.
[11] Mendizabal M, Marciano S, Videla M G, et al. Fulminant presentation of autoimmune hepatitis: clinical features and early predictors of corticosteroid treatment failure. Eur J Gastroenterol Hepatol,2015,27(6):644-648.
[12] Peiseler M, Liebscher T, Sebode M, et al. Efficacy andlimitations of budesonide as a second-line treatment for patients with autoimmune hepatitis.Clin Gastroenterol Hepatol, 2018,16(2):260-267.
[13] Woynarowski M, Nemeth A, Baruch Y, et al. Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents. J Pediatr,2013,163(5):1347-1353.
[14] Zachou K, Gatselis N, Papadamou G, et al. Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-native patients.J Hepatol,2011,55(3):636-646.
[15] Liwinski T,Schramm C. Autoimmune hepatitis -update on clinical management in 2017. Clin Res Hepatol Gastroenterol,2017,41(6):617-625.
[16] Burak K W, Swain M G, Santodomino-Garzon T, et al. Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy. Can J Gastroenterol,2013,27(5):273-280.
[17] 张玮, 刘一博, 王俐琼,等. 调免Ⅰ号联合熊去氧胆酸胶囊治疗自身免疫性肝炎的临床观察. 中西医结合肝病杂志, 2009, 19(2):78-80.
[18] 王艳丽, 吴东. 中西医结合治疗自身免疫性肝炎临床观察. 湖北中医杂志, 2013, 35(11):18-19.
[19] 张红星, 刘旭东. 中西医结合治疗自身免疫性肝炎30例观察. 实用中医药杂志, 2016, 32(6):555-556.
[20] Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis.Lancet, 2015, 386(10003):1565-1575.
[21] Hirschfield GM, Beuers U, Corpechot C, et al. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis.J Hepatol,2017,67(1):145-172.
[22] Parés A, Caballería L, Rodés J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid. Gastroenterology, 2006,130(3):715-720.
[23] Quarneti C, Muratori P, Lalanne C, et al. Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis. Liver Int, 2015, 35(2):636-641.
[24] Ter Borg P C, Schalm S W, Hansen B E, et al. Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients. Am J Gastroenterol,2006,101(9):2044-2050.
[25] Zhu G Q, Shi K Q, Huang S, et al. Network Meta-analysis of randomized controlled trials: Efficacy and safety of UDCA-based therapies in primary biliary cirrhosis. Medicine, 2015, 94(11):e609.
[26] Hirschfield G M, Mason A, Luketic V, et al. Efficacy ofobeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid. Gastroenterology,2015,148(4):751-761.

Chinese herbal and western medicine combination in treatment of patients with autoimmune liver disease

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Ai Guo, Wang Ming, Zhu Jiling, et al.. Preliminary study on the clinical efficacy of N-acetylcysteine in the treatment of patients with chronic icteric hepatitis B [J]. Journal of Practical Hepatology, 2020, 23(3): 336-339.
[2]	Fang Lijuan, Wu Xiongfei. Application ofentecavir in the treatment of patients with hepatitis B virus carrier and pulmonary tuberculosis during antituberculotic therapy [J]. Journal of Practical Hepatology, 2020, 23(3): 340-343.
[3]	Fu Chuishi,Zhang Jiewei. Virological and biochemical response in children with chronic hepatitis C by using peginterferon-α2a and ribavirin combination treatment [J]. Journal of Practical Hepatology, 2020, 23(3): 344-347.
[4]	Du Ying, Jiang Zhihong, Wu Yaling. Efficacy of tripterygium wilfordii polyglycosides and magnesium isoglycyrrhizinate combination in the treatment of children with autoimmune hepatitis [J]. Journal of Practical Hepatology, 2020, 23(3): 348-351.
[5]	Wu Zhimin,Yang Yonghuang,Bian Xiangli. Changes of CD4⁺ and CD8⁺T cells in peripheral blood in children and adolescents with autoimmune hepatitis [J]. Journal of Practical Hepatology, 2020, 23(3): 352-355.
[6]	Feng Jing, Luo Sijian, Li Jing,et al. Expression of inflammatory factors in liver tissues of patients with different types of autoimmune liver diseases [J]. Journal of Practical Hepatology, 2020, 23(3): 356-359.
[7]	Sun Huiqing, Zhang Shufeng, Cui Shilan, et al.. Short-term efficacy of ornithine aspartate and a herbal compound combination in treatment of patients with hepatitis B liver cirrhosis complicated by hepatic encephalopathy [J]. Journal of Practical Hepatology, 2020, 23(3): 405-408.
[8]	Wang Liangliang,Yang Bo,Zhang Weiguo. Comparison of fluorescent laparoscopic hepatectomy and conventional laparoscopic hepatectomy in the treatment of patients with HCC [J]. Journal of Practical Hepatology, 2020, 23(3): 427-430.
[9]	Li Wei, Wang Xibin,Cui Weidong, et al. Efficacy of ultrasound-guided percutaneous transhepatic cholangiography in the treatment of patients with acute obstructive suppurative cholangitis [J]. Journal of Practical Hepatology, 2020, 23(3): 447-450.
[10]	Wang Yunhua, Ma Dan, Ma Limin, et al. Application of bicyclol in children with EB viral hepatitis [J]. Journal of Practical Hepatology, 2020, 23(3): 451-452.
[11]	Zhang Xiaowei, Zhong Rui. Short-term efficacy and tolerance ofsofosbuvir/velpatasvir and ribavirin combination in the treatment of hepatitis C patients with genotype 2 or 3 infection [J]. Journal of Practical Hepatology, 2020, 23(2): 191-194.
[12]	Jia Chen, Zhang Tao, Wang Hao, et al. Efficacy of liraglutide in treatment of patients with nonalcoholic fatty liver disease complicated by type 2 diabetes mellitus [J]. Journal of Practical Hepatology, 2020, 23(2): 203-206.
[13]	Wang Hongxue, Zhu Qingjing, Zhang Yujuan , et al. Efficacy of cetylcysteine combined with magnesium isoglycyrrhizinate in treatment of patients with drug-induced liver injuries [J]. Journal of Practical Hepatology, 2020, 23(2): 227-230.
[14]	Zhang Yuling, Zhou Jing, Dong Hongwei. Verification of elastography point quantification by sonography in the diagnosis of hepatic fibrosis in patients with autoimmune liver diseases [J]. Journal of Practical Hepatology, 2020, 23(2): 231-235.
[15]	Li Yongchao, Ren Hongjun, Liu Lei, et al. Clinical efficacy of double plasma adsorption and plasma exchange in treatment of patients with acute-on-chronic hepatitis B liver failure [J]. Journal of Practical Hepatology, 2020, 23(2): 236-239.